search returned 100 results for adalimumab, showing results 81 to 90
completed except – Pharmacy issues re:
adalimumab biosimilars and supply of Humira as still pending... to review and upload
to ARA website once finalised.
9 Pharmacy issues re: adalimumab biosimilars
https://rheumatology.org.au/LinkClick.aspx?fileticket=sVdsx0fL1uU%3d&portalid=2
of a paediatric rheumatology centre
Where the term 'biological agent' appears, it refers to adalimumab... of neutropaenia
Adalimumab
Etanercept
Tocilizumab
Abatacept
Anakinra (Systemic JIA only)
Rituximab (RhF
https://rheumatology.org.au/LinkClick.aspx?fileticket=zfbltWYPPn4%3d&portalid=2
was
undertaken prior to the widespread availability of adalimumab biosimilars and
encourage any... adalimumab listing as a HSD not general schedule listing
5. The APRG estimate that patients who receive adalimumab or etanercept on compassionate
grounds for non-PBS indications (uveitis or SaJIA
https://rheumatology.org.au/LinkClick.aspx?fileticket=fc8TZ8OEmHA%3d
was
undertaken prior to the widespread availability of adalimumab biosimilars and
encourage any... adalimumab listing as a HSD not general schedule listing
5. The APRG estimate that patients who receive adalimumab or etanercept on compassionate
grounds for non-PBS indications (uveitis or SaJIA
https://rheumatology.org.au/LinkClick.aspx?fileticket=fc8TZ8OEmHA%3d&portalid=2
also highlighted some recent positive PBAC recommendations, namely:
o new paediatric adalimumab... listing for adalimumab for severe active JIA (reduced
MTX dose 15mg/m
2
, changes to prescribing...
leaflets as due for review which were assigned as follows:
o Adalimumab - HC
o Biosimilars - WR
o
https://rheumatology.org.au/LinkClick.aspx?fileticket=XMihBJeYOCM%3d
also highlighted some recent positive PBAC recommendations, namely:
o new paediatric adalimumab... listing for adalimumab for severe active JIA (reduced
MTX dose 15mg/m
2
, changes to prescribing...
leaflets as due for review which were assigned as follows:
o Adalimumab - HC
o Biosimilars - WR
o
https://rheumatology.org.au/LinkClick.aspx?fileticket=XMihBJeYOCM%3d&portalid=2
and had been stable on
adalimumab for ankylosing spondylitis. Despite documentation of prior use
https://rheumatology.org.au/LinkClick.aspx?fileticket=4hcCcsBBYJM%3d
idiopathic
arthritis (JIA)
- Systemic
juvenile
idiopathic
arthritis (sJIA)
- Adalimumab
(JIA only
https://rheumatology.org.au/LinkClick.aspx?fileticket=bwLwzYKPKn8%3d
health
care provider.
Some brand names include:
Adalimumab: Amgevita, Hadlima, Hyrimoz, Idacio
https://rheumatology.org.au/LinkClick.aspx?fileticket=FArs5lkpnCQ%3d
and had been stable on
adalimumab for ankylosing spondylitis. Despite documentation of prior use
https://rheumatology.org.au/LinkClick.aspx?fileticket=4hcCcsBBYJM%3d&portalid=2